Genomma Lab Internacional, S.A.B. de C.V. Share Price
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.96 MXN | -0.86% |
|
-0.60% | -16.38% |
| Market Cap | 1.46TCr 84Cr 73Cr 68Cr 63Cr 118.65Cr 7.89TCr 121.11Cr 812.32Cr 314.32Cr 3.9TCr 314Cr 307.15Cr 14TCr | P/E 2026 * |
6.82x | P/E 2027 * | 6.74x |
|---|---|---|---|---|---|
| Enterprise Value | 1.85TCr 105.76Cr 93Cr 85Cr 80Cr 150.05Cr 9.98TCr 153.17Cr 1.03TCr 397.52Cr 4.93TCr 397.12Cr 388.45Cr 17TCr | EV / Sales 2026 * |
1.01x | EV / Sales 2027 * | 0.94x |
| Free-Float |
68.95% | Yield 2026 * |
5.36% | Yield 2027 * | 7.34% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -0.86% | ||
| 1 week | -0.60% | ||
| Current month | -6.38% | ||
| 1 month | -5.79% | ||
| 3 months | -15.05% | ||
| 6 months | -17.26% | ||
| Current year | -16.38% |
| 1 week | 14.24 |  | 15.16 |
| 1 month | 14.24 | | 16.19 |
| Current year | 14.24 | | 19.48 |
| 1 year | 14.24 | | 23.6 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Investor Relations Contact | - | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | 01/01/2017 | |
| Chairman | - | 30/10/1996 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | -0.60% | -28.35% | +7.70% | 84Cr | |
| +7.13% | +9.97% | +51.94% | +166.83% | 1,07700Cr | |
| +3.99% | +11.50% | +67.53% | +55.63% | 61TCr | |
| +4.20% | +17.03% | +35.63% | +87.74% | 45TCr | |
| +0.99% | +4.85% | +27.93% | +22.82% | 33TCr | |
| +1.82% | +8.19% | +41.15% | +26.80% | 29TCr | |
| +0.22% | +6.75% | +31.51% | +42.02% | 29TCr | |
| +0.73% | +8.53% | -26.22% | -40.85% | 21TCr | |
| +1.56% | +6.14% | +28.38% | +59.45% | 19TCr | |
| +3.26% | +3.33% | +18.83% | +67.03% | 16TCr | |
| Average | +1.77% | +7.65% | +24.83% | +49.52% | 36.17TCr | |
| Weighted average by Cap. | +2.26% | +8.93% | +40.50% | +81.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.83TCr 105.02Cr 92Cr 85Cr 79Cr 149Cr 9.91TCr 152.1Cr 1.02TCr 394.74Cr 4.9TCr 394.34Cr 385.73Cr 17TCr | 1.92TCr 110.26Cr 97Cr 89Cr 83Cr 156.44Cr 10TCr 159.69Cr 1.07TCr 414.45Cr 5.14TCr 414.03Cr 404.99Cr 18TCr |
| Net income | 213.66Cr 12Cr 11Cr 9.9Cr 9.27Cr 17Cr 1.16TCr 18Cr 118.96Cr 46Cr 570.92Cr 46Cr 45Cr 1.98TCr | 225.08Cr 13Cr 11Cr 10Cr 9.76Cr 18Cr 1.22TCr 19Cr 125.32Cr 48Cr 601.45Cr 48Cr 47Cr 2.09TCr |
| Net Debt | 386.19Cr 22Cr 19Cr 18Cr 17Cr 31Cr 2.09TCr 32Cr 215.02Cr 83Cr 1.03TCr 83Cr 81Cr 3.58TCr | 346.39Cr 20Cr 17Cr 16Cr 15Cr 28Cr 1.87TCr 29Cr 192.86Cr 75Cr 925.6Cr 75Cr 73Cr 3.21TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | MX$14.96 | -0.86% | 39,86,049 |
| 25/26/25 | MX$15.09 | +2.65% | 41,10,913 |
| 24/26/24 | MX$14.70 | +2.37% | 32,39,505 |
| 23/26/23 | MX$14.36 | +0.28% | 33,69,521 |
| 22/26/22 | MX$14.32 | -4.85% | 45,48,372 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
